Go Pro
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel Free FBIOP Stock Alerts

Fortress Biotech (FBIOP) Competitors

Fortress Biotech logo
$18.73 +0.12 (+0.64%)
As of 03:55 PM Eastern
Compare

FBIOP vs. SXTPW, BFRIW, CALA, CINGW, and CMRAW

Should you buy Fortress Biotech stock or one of its competitors? Fortress Biotech's main competitors and comparable companies include 60 Degrees Pharmaceuticals (SXTPW), Biofrontera (BFRIW), Calithera Biosciences (CALA), Cingulate (CINGW), and Comera Life Sciences (CMRAW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Fortress Biotech compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Fortress Biotech (NASDAQ:FBIOP) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk and earnings.

In the previous week, 60 Degrees Pharmaceuticals and 60 Degrees Pharmaceuticals both had 1 articles in the media. 60 Degrees Pharmaceuticals' average media sentiment score of 1.89 beat Fortress Biotech's score of 1.87 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
60 Degrees Pharmaceuticals Very Positive
Fortress Biotech Very Positive

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
Fortress Biotech N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.11MN/AN/AN/AN/A
Fortress Biotech$68.47MN/AN/AN/AN/A

Summary

60 Degrees Pharmaceuticals and Fortress Biotech tied by winning 1 of the 2 factors compared between the two stocks.

How does Fortress Biotech compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Fortress Biotech (NASDAQ:FBIOP) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation, media sentiment and earnings.

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
Fortress Biotech N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$46.18MN/AN/AN/AN/A
Fortress Biotech$68.47MN/AN/AN/AN/A

In the previous week, Biofrontera and Biofrontera both had 1 articles in the media. Biofrontera's average media sentiment score of 1.87 equaled Fortress Biotech'saverage media sentiment score.

Company Overall Sentiment
Biofrontera Very Positive
Fortress Biotech Very Positive

Summary

Fortress Biotech beats Biofrontera on 1 of the 1 factors compared between the two stocks.

How does Fortress Biotech compare to Calithera Biosciences?

Fortress Biotech (NASDAQ:FBIOP) and Calithera Biosciences (NASDAQ:CALA) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, media sentiment, dividends, analyst recommendations and risk.

Fortress Biotech has higher revenue and earnings than Calithera Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fortress Biotech$68.47MN/AN/AN/AN/A
Calithera BiosciencesN/AN/A-$39.65MN/AN/A

Company Net Margins Return on Equity Return on Assets
Fortress BiotechN/A N/A N/A
Calithera Biosciences N/A N/A N/A

In the previous week, Fortress Biotech and Fortress Biotech both had 1 articles in the media. Fortress Biotech's average media sentiment score of 1.87 beat Calithera Biosciences' score of 0.00 indicating that Fortress Biotech is being referred to more favorably in the media.

Company Overall Sentiment
Fortress Biotech Very Positive
Calithera Biosciences Neutral

Summary

Fortress Biotech beats Calithera Biosciences on 2 of the 2 factors compared between the two stocks.

How does Fortress Biotech compare to Cingulate?

Cingulate (NASDAQ:CINGW) and Fortress Biotech (NASDAQ:FBIOP) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, media sentiment, dividends and earnings.

In the previous week, Cingulate had 1 more articles in the media than Fortress Biotech. MarketBeat recorded 2 mentions for Cingulate and 1 mentions for Fortress Biotech. Fortress Biotech's average media sentiment score of 1.87 beat Cingulate's score of 0.44 indicating that Fortress Biotech is being referred to more favorably in the news media.

Company Overall Sentiment
Cingulate Neutral
Fortress Biotech Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CingulateN/AN/AN/AN/AN/A
Fortress Biotech$68.47MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
CingulateN/A N/A N/A
Fortress Biotech N/A N/A N/A

Summary

Fortress Biotech beats Cingulate on 2 of the 3 factors compared between the two stocks.

How does Fortress Biotech compare to Comera Life Sciences?

Fortress Biotech (NASDAQ:FBIOP) and Comera Life Sciences (NASDAQ:CMRAW) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk.

Company Net Margins Return on Equity Return on Assets
Fortress BiotechN/A N/A N/A
Comera Life Sciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fortress Biotech$68.47MN/AN/AN/AN/A
Comera Life Sciences$1.00MN/AN/AN/AN/A

In the previous week, Fortress Biotech had 1 more articles in the media than Comera Life Sciences. MarketBeat recorded 1 mentions for Fortress Biotech and 0 mentions for Comera Life Sciences. Fortress Biotech's average media sentiment score of 1.87 beat Comera Life Sciences' score of 0.00 indicating that Fortress Biotech is being referred to more favorably in the media.

Company Overall Sentiment
Fortress Biotech Very Positive
Comera Life Sciences Neutral

Summary

Fortress Biotech beats Comera Life Sciences on 3 of the 3 factors compared between the two stocks.

Get Fortress Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for FBIOP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FBIOP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FBIOP vs. The Competition

Export
MetricFortress BiotechPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$12.02B$7.13B$12.83B
Dividend Yield12.11%2.62%2.54%11.27%
P/E RatioN/A785.17272.9225.51
Price / SalesN/A957.43686.04122.84
Price / CashN/A15.3228.7436.03
Price / BookN/A10.4611.056.33
Net IncomeN/A$2.83B$3.47B$349.45M
7 Day Performance1.85%0.24%1.24%-0.09%
1 Month Performance-0.79%5.34%8.25%4.37%
1 Year Performance128.69%5.98%24.13%14.79%

Fortress Biotech Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FBIOP
Fortress Biotech
N/A$18.73
+0.6%		N/A+127.2%$0.00$68.47MN/A170
SXTPW
60 Degrees Pharmaceuticals
N/A$0.04
flat		N/A-58.7%$0.00$1.00MN/A2
BFRIW
Biofrontera
N/A$0.03
+0.3%		N/A-81.6%$0.00$43.20MN/A70
CALA
Calithera Biosciences
N/AN/AN/A+50.0%$0.00N/AN/A60
CINGW
Cingulate
N/A$0.01
+26.9%		N/AN/A$0.00N/AN/A20

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:FBIOP) was last updated on 8/31/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel